These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 25256594)

  • 1. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
    Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
    Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
    Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
    Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salpingectomy and Ovarian Cancer Prevention.
    Harris AL
    Nurs Womens Health; 2015 Dec-2016 Jan; 19(6):543-9. PubMed ID: 26682662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of ovarian cancer after salpingectomy and tubal ligation: Prospects on histology and time since the procedure.
    Duus AH; Zheng G; Baandrup L; Faber MT; Kjær SK
    Gynecol Oncol; 2023 Oct; 177():125-131. PubMed ID: 37683548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
    Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
    Rice MS; Hankinson SE; Tworoger SS
    Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.
    Lessard-Anderson CR; Handlogten KS; Molitor RJ; Dowdy SC; Cliby WA; Weaver AL; Sauver JS; Bakkum-Gamez JN
    Gynecol Oncol; 2014 Dec; 135(3):423-7. PubMed ID: 25316178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salpingectomy as a means to reduce ovarian cancer risk.
    Daly MB; Dresher CW; Yates MS; Jeter JM; Karlan BY; Alberts DS; Lu KH
    Cancer Prev Res (Phila); 2015 May; 8(5):342-8. PubMed ID: 25586903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
    Modugno F; Ness RB; Wheeler JE
    Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
    Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
    Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription use of paracetamol and risk for ovarian cancer in Denmark.
    Baandrup L; Friis S; Dehlendorff C; Andersen KK; Olsen JH; Kjaer SK
    J Natl Cancer Inst; 2014 Jun; 106(6):dju111. PubMed ID: 24848623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
    Ely LK; Truong M
    J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.
    Sieh W; Salvador S; McGuire V; Weber RP; Terry KL; Rossing MA; Risch H; Wu AH; Webb PM; Moysich K; Doherty JA; Felberg A; Miller D; Jordan SJ; ; ; Goodman MT; Lurie G; Chang-Claude J; Rudolph A; Kjær SK; Jensen A; Høgdall E; Bandera EV; Olson SH; King MG; Rodriguez-Rodriguez L; Kiemeney LA; Marees T; Massuger LF; van Altena AM; Ness RB; Cramer DW; Pike MC; Pearce CL; Berchuck A; Schildkraut JM; Whittemore AS;
    Int J Epidemiol; 2013 Apr; 42(2):579-89. PubMed ID: 23569193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.